Skip To The Main Content

Browse these ideas available for licensing that have the potential to improve lives while creating jobs to support and grow the region.

All technologies
 are listed as non-confidential technical summaries.

Technologies were generated by academic institutions, entrepreneurs, and corporations.

Click the Tech Search button below to have Whiteboard 2 Boardroom® staff complete a personalized search for innovations to license from our research institution partners.

The most recent innovations from our partners are featured separately and organized by category. All listings are updated as new technology opportunities become available. 

For assistance in connecting with, or attaining further information on any of these technologies, please contact us.

Rocky Mountain Spotted Fever Canine Vaccine

Researchers have created an inactivated canine vaccine candidate to prevent Rocky Mountain Spotted Fever (RMSF) infection.

RMSF is considered a biosecurity level 3 pathogen because it can infect humans. Kansas State University has the unique facilities and expertise to handle such a pathogen.

Two vaccine candidates were created and tested in host animal studies:
  • whole cell inactivated vaccine
  • recombinant vaccine having two immunogenic proteins.
Dogs receiving the whole cell inactivated vaccine abated clinical signs completely and the pathogen from circulation. Dogs in the recombinant vaccine group did not show any obvious differences in clinical signs compared to non-vaccinated control group. These early results indicate the whole cell inactivated vaccine candidate could hold more promise for vaccine development and should be studied further.

  • RMSF vaccine for dogs

Additional Details


Kansas State University

Intellectual Property Protection

Pending Patent

Interested? Request More Information